Endexx Corp. announced that its recently-acquired HYLA division, in which the company has a controlling interest, has secured two major purchase orders for its new innovative vape-delivery product that holds 4,500 puffs per built-in cartridge unit.
The developer and distributor of all natural, plant-derived topical skincare products said combined, the orders represent a 150,000-unit order and a 52,000-unit order for over 200,000 units within the first month of the acquisition of Hyla.
“The two purchase orders came from prominent distributors in the West Coast region of the US and a large western region in Asia,” Endexx Corporation CEO Todd Davis said in a statement.
READ: Endexx Corporation says new subsidiary HYLA looks to expand into eight new markets
“These orders expand both our international and domestic distribution networks helping to expedite our growth initiatives,” Davis added.
Formulated with Guarana and Levodopa, the zero-nicotine vape product is forecasted to replace the recently-banned nicotine products sold internationally where vape products are available, Endexx noted.
The company added that the expanded puff capacity far exceeds the capacity of its competitors' products worldwide.
Through its operating division CBD Unlimited, Endexx develops and distributes all-natural CBD products derived from cannabis sativa plants containing less than 0.1% THC. Its products include oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief.
Contact Sean at sean@proactiveinvestors.com